| Literature DB >> 35883359 |
Lorenzo Gambi1,2, Rachele Rossini1, Maria Luisa Menandro3, Giovanni Franzo3, Francesco Valentini1, Giovanni Tosi1, Mario D'Incau4, Laura Fiorentini1.
Abstract
Colibacillosis is the most common bacterial disease in the poultry industry. The isolation of Escherichia coli (E. coli) strains with multiple resistance to various classes of antimicrobials has been increasing in recent years. In this study, antimicrobial resistance features, serotyping and the presence of avian pathogenic Escherichia coli (APEC) virulence genes were investigated on a total of 71 E. coli strains isolated during outbreaks of colibacillosis in laying hens. The correlation between these features was evaluated. The most frequently isolated serogroups were O2 and O88. Resistance was often detected with nalidixic acid (49%) and ampicillin (38%), while all strains were sensitive to ceftiofur and florfenicol. Overall, 25% of the isolates showed resistance to at least three or more antimicrobial classes (multidrug-resistant strains), and 56% of the isolates were defined as APEC strains (due to the presence of at least five virulence genes). Correlation between the different parameters (virulence genes, serogroup and antimicrobial resistance) did not reveal relevant associations. The comparison of the obtained results with those of similar studies highlighted the importance of continuous monitoring in order to have a better understanding of colibacillosis. An evaluation of the national epidemiological situation would allow, especially with regard to antimicrobial resistance, to focus on the right measures in order to prioritize the available resources for effective disease control.Entities:
Keywords: APEC; MDR; avian pathogenic Escherichia coli; colibacillosis; laying hens
Year: 2022 PMID: 35883359 PMCID: PMC9311855 DOI: 10.3390/ani12141812
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
Expected product size for each amplified gene of the positive control.
| n. of Band in Positive Control Lane | Amplified Gene | Expected Product Size |
|---|---|---|
| 1 | astA | 111 bp |
| 2 | iss | 309 bp |
| 3 | irp2 | 413 bp |
| 4 | pap C | 501 bp |
| 5 | cvi/cva | 598 bp |
| 6 | iucD | 693 bp |
| 7 | tsh | 824 bp |
| 8 | vat | 978 bp |
Figure 1Bar chart reporting the percentages of E. coli strains found to be sensitive (S), have increased exposure sensitivity (I) or be resistant (R) to the various antimicrobial molecules tested.
Distribution of virulence genes in E. coli strains.
| Genes | Negative | Positive | ||
|---|---|---|---|---|
| astA | 67 | 94% | 4 | 6% |
| iss | 7 | 10% | 64 | 90% |
| irp2 | 21 | 30% | 50 | 70% |
| papC | 61 | 86% | 10 | 14% |
| cvi/cva | 21 | 30% | 50 | 70% |
| iucD | 11 | 15% | 60 | 85% |
| tsh | 26 | 37% | 45 | 63% |
| vat | 46 | 65% | 25 | 35% |
Figure 2Virulence gene distribution in O2 and O88 E. coli strains.